CD8A and melanoma: Employing a cDC1-targeted vaccine model using the melanoma antigen human gp100 (hgp100), we further demonstrated that treatment with anti-Tim-3 restored cross-priming and memory responses of gp100-specific CD8 T cells in CD11c-β-cateninactive mice.